480 related articles for article (PubMed ID: 22303460)
21. Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer.
McCaw TR; Goel N; Brooke DJ; Katre AA; Londoño AI; Smith HJ; Randall TD; Arend RC
Cancer Med; 2021 Jan; 10(2):709-717. PubMed ID: 33369199
[TBL] [Abstract][Full Text] [Related]
22. HDAC5 controls the functions of Foxp3(+) T-regulatory and CD8(+) T cells.
Xiao H; Jiao J; Wang L; O'Brien S; Newick K; Wang LC; Falkensammer E; Liu Y; Han R; Kapoor V; Hansen FK; Kurz T; Hancock WW; Beier UH
Int J Cancer; 2016 May; 138(10):2477-86. PubMed ID: 26704363
[TBL] [Abstract][Full Text] [Related]
23. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
24. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors.
Hashimoto A; Fukumoto T; Zhang R; Gabrilovich D
Cancer Immunol Immunother; 2020 Sep; 69(9):1929-1936. PubMed ID: 32435850
[TBL] [Abstract][Full Text] [Related]
25. Entinostat for the treatment of breast cancer.
Trapani D; Esposito A; Criscitiello C; Mazzarella L; Locatelli M; Minchella I; Minucci S; Curigliano G
Expert Opin Investig Drugs; 2017 Aug; 26(8):965-971. PubMed ID: 28718331
[TBL] [Abstract][Full Text] [Related]
26. The histone deacetylase inhibitor Entinostat enhances polymer-mediated transgene expression in cancer cell lines.
Elmer JJ; Christensen MD; Barua S; Lehrman J; Haynes KA; Rege K
Biotechnol Bioeng; 2016 Jun; 113(6):1345-1356. PubMed ID: 26614912
[TBL] [Abstract][Full Text] [Related]
27. Histone deacetylase inhibition promotes intratumoral CD8
McCaw TR; Li M; Starenki D; Liu M; Cooper SJ; Arend RC; Forero A; Buchsbaum DJ; Randall TD
Cancer Immunol Immunother; 2019 Dec; 68(12):2081-2094. PubMed ID: 31720815
[TBL] [Abstract][Full Text] [Related]
28. Preclinical rationale for entinostat in embryonal rhabdomyosarcoma.
Bharathy N; Berlow NE; Wang E; Abraham J; Settelmeyer TP; Hooper JE; Svalina MN; Bajwa Z; Goros MW; Hernandez BS; Wolff JE; Pal R; Davies AM; Ashok A; Bushby D; Mancini M; Noakes C; Goodwin NC; Ordentlich P; Keck J; Hawkins DS; Rudzinski ER; Mansoor A; Perkins TJ; Vakoc CR; Michalek JE; Keller C
Skelet Muscle; 2019 May; 9(1):12. PubMed ID: 31113472
[TBL] [Abstract][Full Text] [Related]
29. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
Akimova T; Ge G; Golovina T; Mikheeva T; Wang L; Riley JL; Hancock WW
Clin Immunol; 2010 Sep; 136(3):348-63. PubMed ID: 20478744
[TBL] [Abstract][Full Text] [Related]
30. Histone deacetylase inhibitors and transplantation.
Tao R; de Zoeten EF; Ozkaynak E; Wang L; Li B; Greene MI; Wells AD; Hancock WW
Curr Opin Immunol; 2007 Oct; 19(5):589-95. PubMed ID: 17719760
[TBL] [Abstract][Full Text] [Related]
31. The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3.
Ni L; Wang L; Yao C; Ni Z; Liu F; Gong C; Zhu X; Yan X; Watowich SS; Lee DA; Zhu S
Sci Rep; 2017 Mar; 7():45266. PubMed ID: 28338101
[TBL] [Abstract][Full Text] [Related]
32. Resistance after chronic application of the HDAC-inhibitor valproic acid is associated with elevated Akt activation in renal cell carcinoma in vivo.
Juengel E; Makarević J; Tsaur I; Bartsch G; Nelson K; Haferkamp A; Blaheta RA
PLoS One; 2013; 8(1):e53100. PubMed ID: 23372654
[TBL] [Abstract][Full Text] [Related]
33. The attenuation of renal fibrosis by histone deacetylase inhibitors is associated with the plasticity of FOXP3
Wu WP; Tsai YG; Lin TY; Wu MJ; Lin CY
BMC Nephrol; 2017 Jul; 18(1):225. PubMed ID: 28693431
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic modulation of retinoic acid receptor beta2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma.
Wang XF; Qian DZ; Ren M; Kato Y; Wei Y; Zhang L; Fansler Z; Clark D; Nakanishi O; Pili R
Clin Cancer Res; 2005 May; 11(9):3535-42. PubMed ID: 15867257
[TBL] [Abstract][Full Text] [Related]
35. Cladribine in combination with entinostat synergistically elicits anti-proliferative/anti-survival effects on multiple myeloma cells.
Wang B; Lyu H; Pei S; Song D; Ni J; Liu B
Cell Cycle; 2018; 17(8):985-996. PubMed ID: 29969371
[TBL] [Abstract][Full Text] [Related]
36. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780
[TBL] [Abstract][Full Text] [Related]
37. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
[TBL] [Abstract][Full Text] [Related]
38. Increased intratumoral FOXP3-positive regulatory immune cells during interleukin-2 treatment in metastatic renal cell carcinoma.
Jensen HK; Donskov F; Nordsmark M; Marcussen N; von der Maase H
Clin Cancer Res; 2009 Feb; 15(3):1052-8. PubMed ID: 19188179
[TBL] [Abstract][Full Text] [Related]
39. Histone Deacetylase Inhibitor Enhances the Efficacy of MEK Inhibitor through NOXA-Mediated MCL1 Degradation in Triple-Negative and Inflammatory Breast Cancer.
Torres-Adorno AM; Lee J; Kogawa T; Ordentlich P; Tripathy D; Lim B; Ueno NT
Clin Cancer Res; 2017 Aug; 23(16):4780-4792. PubMed ID: 28465444
[No Abstract] [Full Text] [Related]
40. [Active immunotherapy of urologic malignancies and tumor-mediated immunosuppression].
Kübler H; Gschwend JE
Urologe A; 2008 Sep; 47(9):1122-7. PubMed ID: 18704362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
